Envestnet, Inc. Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share

3 Months Ended

Mar. 31, 2023

Securities that were anti-dilutive and therefore excluded from the computation of diluted net loss per share were as follows:


	Three Months Ended
	March 31,
		2023	2022

		(in thousands)
Options to purchase common stock		240,081	326,300
Non-vested RSUs and PSUs		2,431,316	2,641,362
Convertible Notes		11,470,645	9,898,549
Warrants		—	470,000
Total anti-dilutive securities		14,142,042	13,336,211